• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利一家综合癌症中心的乳腺癌临床登记系统:一个用于描述性、临床和实验性研究的工具。

A breast cancer clinical registry in an Italian comprehensive cancer center: an instrument for descriptive, clinical, and experimental research.

作者信息

Baili Paolo, Torresani Michele, Agresti Roberto, Rosito Giuseppe, Daidone Maria Grazia, Veneroni Silvia, Cavallo Ilaria, Funaro Francesco, Giunco Marco, Turco Alberto, Amash Hade, Scavo Antonio, Minicozzi Pamela, Bella Francesca, Meneghini Elisabetta, Sant Milena

机构信息

Analytic Epidemiology and Health Impact Unit, Fondazione IRCCS "Istituto Nazionale dei Tumori", Milan - Italy.

出版信息

Tumori. 2015 Jul-Aug;101(4):440-6. doi: 10.5301/tj.5000341. Epub 2015 May 2.

DOI:10.5301/tj.5000341
PMID:25953447
Abstract

In clinical research, many potentially useful variables are available via the routine activity of cancer center-based clinical registries (CCCR). We present the experience of the breast cancer clinical registry at Fondazione IRCCS "Istituto Nazionale dei Tumori" to give an example of how a CCCR can be planned, implemented, and used. Five criteria were taken into consideration while planning our CCCR: (a) available clinical and administrative databases ought to be exploited to the maximum extent; (b) open source software should be used; (c) a Web-based interface must be designed; (d) CCCR data must be compatible with population-based cancer registry data; (e) CCCR must be an open system, able to be connected with other data repositories. The amount of work needed for the implementation of a CCCR is inversely linked with the amount of available coded data: the fewer data are available in the input databases as coded variables, the more work will be necessary, for information technology staff, text mining analysis, and registrars (for collecting data from clinical records). A cancer registry in a comprehensive cancer center can be used for several research aspects, such as estimate of the number of cases needed for clinical studies, assessment of biobank specimens with specific characteristics, evaluation of clinical practice and adhesion to clinical guidelines, comparative studies between clinical and population sets of patients, studies on cancer prognosis, and studies on cancer survivorship.

摘要

在临床研究中,通过以癌症中心为基础的临床登记系统(CCCR)的日常活动可获取许多潜在有用的变量。我们介绍了意大利国家肿瘤研究所(Fondazione IRCCS "Istituto Nazionale dei Tumori")乳腺癌临床登记系统的经验,以举例说明如何规划、实施和使用CCCR。在规划我们的CCCR时考虑了五个标准:(a)应最大限度地利用现有的临床和行政数据库;(b)应使用开源软件;(c)必须设计基于网络的界面;(d)CCCR数据必须与基于人群的癌症登记数据兼容;(e)CCCR必须是一个开放系统,能够与其他数据存储库连接。实施CCCR所需的工作量与可用编码数据量成反比:输入数据库中作为编码变量可用的数据越少,信息技术人员、文本挖掘分析人员和登记员(用于从临床记录中收集数据)所需的工作量就越大。综合癌症中心的癌症登记系统可用于多个研究方面,如估计临床研究所需的病例数、评估具有特定特征的生物样本库标本、评估临床实践和对临床指南的遵循情况、临床患者组与人群患者组之间的比较研究、癌症预后研究以及癌症生存研究。

相似文献

1
A breast cancer clinical registry in an Italian comprehensive cancer center: an instrument for descriptive, clinical, and experimental research.意大利一家综合癌症中心的乳腺癌临床登记系统:一个用于描述性、临床和实验性研究的工具。
Tumori. 2015 Jul-Aug;101(4):440-6. doi: 10.5301/tj.5000341. Epub 2015 May 2.
2
The organization of clinical trials for oncology at IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale" Napoli and the impact of the OECI accreditation process.那不勒斯IRCCS国家肿瘤研究所“G. 帕斯卡尔基金会”的肿瘤学临床试验组织及欧洲癌症研究与治疗组织(OECI)认证过程的影响。
Tumori. 2015;101 Suppl 1:S33-7. doi: 10.5301/tj.5000465. Epub 2015 Dec 30.
3
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
4
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
5
[Voluntary mediation in healthcare disputes: the experience of the "Fondazione IRCCS Istituto Nazionale dei Tumori" in Milan (Italy)].[医疗纠纷中的自愿调解:米兰(意大利)“Fondazione IRCCS Istituto Nazionale dei Tumori”的经验]
Ig Sanita Pubbl. 2014 Jan-Feb;70(1):29-40.
6
Feasibility of evaluating quality cancer care using registry data and electronic health records: a population-based study.利用登记数据和电子健康记录评估癌症护理质量的可行性:一项基于人群的研究。
Int J Qual Health Care. 2012 Aug;24(4):411-8. doi: 10.1093/intqhc/mzs020. Epub 2012 May 16.
7
The European accreditation of Istituto Tumori Giovanni Paolo II of Bari.巴里乔瓦尼·保罗二世肿瘤研究所的欧洲认证。
Tumori. 2015;101 Suppl 1:S14-8. doi: 10.5301/tj.5000467. Epub 2015 Dec 30.
8
An integrated approach to breast diseases and breast cancer registry and research: BDRS as a web-based multi-institutional model.乳腺疾病与乳腺癌登记及研究的综合方法:作为基于网络的多机构模式的乳腺疾病登记与研究系统(BDRS)
Comput Biol Med. 2007 Oct;37(10):1414-25. doi: 10.1016/j.compbiomed.2007.01.006. Epub 2007 Mar 7.
9
The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts.《患者初始治疗后报告的结局和长期生存评估登记研究:为癌症生存者队列的生理和心理社会结局研究构建基础设施的范围、原理和设计》
Eur J Cancer. 2011 Sep;47(14):2188-94. doi: 10.1016/j.ejca.2011.04.034. Epub 2011 May 27.
10
Ensuring quality in studies linking cancer registries and biobanks.确保癌症登记处和生物库相关研究的质量。
Acta Oncol. 2010 Apr;49(3):368-77. doi: 10.3109/02841860903447069.

引用本文的文献

1
Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world.将HER2低表达乳腺癌的预测和预后数据从临床试验应用到现实世界中。
Front Mol Biosci. 2022 Sep 26;9:996434. doi: 10.3389/fmolb.2022.996434. eCollection 2022.
2
Mammographic density to predict response to neoadjuvant systemic breast cancer therapy.乳腺钼靶密度用于预测新辅助全身乳腺癌治疗的反应。
J Cancer Res Clin Oncol. 2022 Apr;148(4):775-781. doi: 10.1007/s00432-021-03881-3. Epub 2022 Jan 17.
3
Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity before and after Neoadjuvant Chemotherapy.
靶向基因测序以捕捉新辅助化疗前后三阴性乳腺癌的异质性
Cancers (Basel). 2019 Nov 8;11(11):1753. doi: 10.3390/cancers11111753.
4
Axillary nodal involvement by primary tumor features in early breast cancer: an analysis of 2600 patients.早期乳腺癌中原发肿瘤特征对腋窝淋巴结转移的影响:2600 例患者分析。
Clin Transl Oncol. 2020 May;22(5):786-792. doi: 10.1007/s12094-019-02188-7. Epub 2019 Aug 1.
5
Clinical Research Informatics: Supporting the Research Study Lifecycle.临床研究信息学:支持研究项目生命周期
Yearb Med Inform. 2017 Aug;26(1):193-200. doi: 10.15265/IY-2017-022. Epub 2017 Sep 11.